Pregnancy outcomes in myeloproliferative neoplasms: A Mayo Clinic report on 102 pregnancies

coagulation assays. Taken together, these data suggest an association between accelerated TT and thrombosis. Additional studies will be needed to not only confirm this finding in a prospective cohort but also deconvolute whether an accelerated TT is associated with an increased risk of a future thrombotic event, or rather indicates the presence of an active thrombus or both. Additionally, the approach utilized here provides an example of how leveraging large volumes of existing laboratory data can uncover potential new significance for routine clinical testing.

[1]  D. Neuberg,et al.  Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera , 2019, Blood.

[2]  A. Tefferi,et al.  Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger , 2018, American journal of hematology.

[3]  S. Bewley,et al.  Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study , 2016, British journal of haematology.

[4]  M. Cazzola,et al.  Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia , 2015, Haematologica.

[5]  J. Puetz Thrombin time and fibrinogen as initial screening tests for people with inherited bleeding disorders , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  R. Latagliata,et al.  Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry , 2009, American journal of hematology.

[7]  A. Tefferi,et al.  Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies , 2009, European journal of haematology.

[8]  M. Cazzola,et al.  Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation. , 2007, Blood.

[9]  Dougald M Monroe,et al.  Coagulation 2006: a modern view of hemostasis. , 2007, Hematology/oncology clinics of North America.

[10]  G. Rodgers,et al.  Comparison of five thrombin time reagents. , 2003, Clinical chemistry.